Pulmonary Aspergillosis: MIRAGE Imaging Study

We are testing a new imaging method using a radioactive substance to see if it helps visualize lung infections caused by Aspergillus. This study aims to improve diagnosis and understanding of this condition.

Efficacy phase (II)No Placebo Standard Medicines InjectionInfectious DiseasesPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Deferoxamine Noridem

Deferoxamine Noridem is a medicine that removes excess iron from the body to treat iron overload or poisoning.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Deferoxamine Mesilate

Deferoxamine mesilate is a substance that binds and helps remove excess iron from the body in people with iron overload.

Gallium (68ga) Chloride

Gallium-68 chloride is a radioactive tracer used in PET scans to help visualize tumors, infections, and other abnormal tissues.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Deferoxamina Noridem

Deferoxaminmesilat Noridem Enterprises

Demoferidon

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Radboud universitair medisch centrum / RADBOUDUMC

Pharmacy

Nijmegen, Netherlands

Sponsor: Radboud universitair medisch centrum / RADBOUDUMC

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.